Vitekta

Country: Նոր Զելանդիա

language: անգլերեն

source: Medsafe (Medicines Safety Authority)

active_ingredient:

Elvitegravir 85mg;  ;  ;  ;  

MAH:

Gilead Sciences (NZ)

INN:

Elvitegravir 85 mg

dosage:

85 mg

pharmaceutical_form:

Film coated tablet

composition:

Active: Elvitegravir 85mg         Excipient: Croscarmellose sodium Hyprolose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Opadry green 85F91203 Sodium laurilsulfate

prescription_type:

Prescription

manufactured_by:

Gilead Sciences Inc

therapeutic_indication:

Indicated for the treatment of HIV-1 infection in antiretroviral treatment-experienced adults and adolescents when co-administered with a ritonavir-boosted protease inhibitor and other antiretroviral therapy.

leaflet_short:

Package - Contents - Shelf Life: Bottle, plastic, HDPE with child resistant PE cap - 30 tablets - 24 months from date of manufacture stored at or below 25°C

authorization_date:

2013-11-04